Seer Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 124

Employees

  • Stock Symbol
  • SEER

Stock Symbol

  • Share Price
  • $1.39
  • (As of Thursday Closing)

Seer General Information

Description

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Contact Information

Website
www.seer.bio
Formerly Known As
Seer Biosciences
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 3800 Bridge Parkway
  • Suite 102
  • Redwood City, CA 94065
  • United States
+1 (650)
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
NAS
Corporate Office
  • 3800 Bridge Parkway
  • Suite 102
  • Redwood City, CA 94065
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seer Stock Performance

As of 19-Nov-2026, Seer’s stock price is $1.39. Its current market cap is $82.9M with 55.8M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.39 $1.44 $1.36 - $2.38 $82.9M 55.8M 216K -$1.14

Seer Financials Summary

As of 30-Sep-2026, Seer has a trailing 12-month revenue of $13.6M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,996 (64,677) (84,888) (178,618)
Revenue 13,618 16,119 13,947 15,182
EBITDA (66,286) (78,817) (96,991) (98,441)
Net Income (63,468) (73,600) (86,599) (86,277)
Total Assets 241,799 296,083 366,597 436,269
Total Debt 21,742 23,652 25,964 28,259
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Seer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Seer‘s full profile, request access.

Request a free trial

Seer Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Seer‘s full profile, request access.

Request a free trial

Seer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The com
Other Healthcare Technology Systems
Redwood City, CA
124 As of 2025

Seattle, WA
 

Billerica, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Seer Competitors (7)

One of Seer’s 7 competitors is Nautilus Biotechnology, a Formerly VC-backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nautilus Biotechnology Formerly VC-backed Seattle, WA
Quanterix Formerly PE-Backed Billerica, MA
Agilent Technologies Formerly PE-Backed Santa Clara, CA
Bio-Rad Laboratories Corporation Hercules, CA
Thermo Fisher Scientific Formerly PE-Backed Waltham, MA
You’re viewing 5 of 7 competitors. Get the full list »

Seer Patents

Seer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026170078-A1 Methods and systems for high-throughput proteomics discovery Pending 06-Feb-2025
WO-2025212750-A1 Biomolecule preparation methods, kits, and systems Pending 03-Apr-2024
US-20250224408-A1 Biomarkers for diagnosing alzheimer's disease and related dementias Pending 05-Jan-2024
US-20250207155-A1 Particle-based bioseparation assays Pending 22-Dec-2023
WO-2025137588-A1 Particle-based bioseparation assays Inactive 22-Dec-2023 C12P1/00
To view Seer’s complete patent history, request access »

Seer Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seer Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Seer‘s full profile, request access.

Request a free trial

Seer ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

33.89 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Seer’s complete esg history, request access »

Seer FAQs

  • When was Seer founded?

    Seer was founded in 2017.

  • Where is Seer headquartered?

    Seer is headquartered in Redwood City, CA.

  • What is the size of Seer?

    Seer has 124 total employees.

  • What industry is Seer in?

    Seer’s primary industry is Other Healthcare Technology Systems.

  • Is Seer a private or public company?

    Seer is a Public company.

  • What is Seer’s stock symbol?

    The ticker symbol for Seer is SEER.

  • What is the current stock price of Seer?

    As of 19-Nov-2026 the stock price of Seer is $1.39.

  • What is the current market cap of Seer?

    The current market capitalization of Seer is $82.9M.

  • What is Seer’s current revenue?

    The trailing twelve month revenue for Seer is $13.6M.

  • Who are Seer’s competitors?

    Nautilus Biotechnology, Quanterix, Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific are some of the 7 competitors of Seer.

  • What is Seer’s annual earnings per share (EPS)?

    Seer’s EPS for 12 months was -$1.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process